Marksans Pharma - Quaterly Results

30 May 2022 Evaluate
The sales for the March 2022 quarter moved up 28.12% to Rs. 1762.78 millions as compared to Rs. 1375.83 millions during the corresponding quarter last year.The Company's Net profit for the March 2022 quarter have declined marginally to Rs. 214.27  millions as against Rs. 236.88 millions reported during the corresponding quarter ended.Operating Profit reported a sharp decline to 345.16 millions from 386.87 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 1762.78 1375.83 28.12 6582.89 5995.48 9.80 6582.89 5995.48 9.80
Other Income 76.48 119.08 -35.77 422.51 311.56 35.61 422.51 311.56 35.61
PBIDT 345.16 386.87 -10.78 1559.66 1448.68 7.66 1559.66 1448.68 7.66
Interest 12.78 21.38 -40.22 37.95 53.45 -29.00 37.95 53.45 -29.00
PBDT 332.38 365.49 -9.06 1521.71 1395.23 9.07 1521.71 1395.23 9.07
Depreciation 46.08 41.45 11.17 176.63 151.93 16.26 176.63 151.93 16.26
PBT 286.30 324.04 -11.65 1345.08 1243.30 8.19 1345.08 1243.30 8.19
TAX 72.03 87.16 -17.36 305.20 259.49 17.62 305.20 259.49 17.62
Deferred Tax -11.26 10.58 -206.43 5.04 -22.39 -122.51 5.04 -22.39 -122.51
PAT 214.27 236.88 -9.54 1039.88 983.81 5.70 1039.88 983.81 5.70
Equity 409.31 409.31 0.00 409.31 409.31 0.00 409.31 409.31 0.00
PBIDTM(%) 19.58 28.12 -30.37 23.69 24.16 -1.95 23.69 24.16 -1.95

Marksans Pharma Share Price

183.95 -3.95 (-2.10%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×